NEO

Neutral

NeoGenomics (NASDAQ: NEO) director receives new RSU and stock option grants

NeoGenomics director Carolyn S. Starrett was granted 14,125 Restricted Stock Units and stock options for 9,784 shares of common stock on June 23, 2026...

Stock Titan 3 days ago 0

Neutral

Lynn Tetrault sells 5,307 NEO shares under 10b5-1 (NASDAQ: NEO)

Lynn Tetrault, an officer at NeoGenomics (NEO), sold 5,307 shares of common stock under a 10b5-1 plan on June 9, 2026, for proceeds of $59,905.42. The...

Stock Titan 2 weeks ago 0